T. Worland Stephen's most recent trade in eFFECTOR Therapeutics Inc was a trade of 1,806 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on May 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 15 May 2024 | 1,806 | 12,494 | - | 1.7 | 3,039 | Common Stock |
| eFFECTOR Therapeutics Inc | T. Worland Stephen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 33,799 | 0 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.52 per share. | 11 Aug 2023 | 33,799 | 261,225 | - | 0.5 | 17,575 | Common Stock |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 15 May 2023 | 6,401 | 227,426 | - | 0.5 | 2,938 | Common Stock |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.47 per share. | 15 Nov 2022 | 6,047 | 221,025 | - | 0.5 | 2,832 | Common Stock |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 520,674 | 520,674 | - | - | Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Stephen T. Worland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 15,750 | 15,750 | - | - | Director Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 07 Jun 2022 | 20,000 | 214,978 | - | 1.4 | 27,400 | Common Stock |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 1.53 per share. | 13 May 2022 | 1,837 | 194,978 | - | 1.5 | 2,811 | Common Stock |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 520,674 | 520,674 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 619,018 | 619,018 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 512,339 | 512,339 | - | - | Common Stock | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 289,712 | 289,712 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 220,639 | 220,639 | - | - | Earn-out Right | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 217,284 | 217,284 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 193,141 | 755,480 | - | - | Common Stock | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 144,856 | 144,856 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 75,472 | 75,472 | - | - | Earn-out Right | |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 25 Aug 2021 | 50,000 | 562,339 | - | 10 | 500,000 | Common Stock |
| eFFECTOR Therapeutics Inc | Stephen T. Worland | Director, President and Chief Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 33,799 | 33,799 | - | - | Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Stephen T. Worland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,500 | 10,500 | - | - | Director Stock Option (Right to Buy) |